Partner Content Partner Content People with Chronic Conditions Concerned About “Returning to... People living with chronic conditions remain cautious
Events Partner Content Real-World Evidence 2020: Rare Diseases and Innovative Thera... Explore practical applications of RWE in rare diseases
Partner Content Partner Content PatchAi startup now in the market to support patients and cl... Healthware Ventures invested in PatchAi
Partner Content Partner Content Invitation to SMI’s Orphan Drugs & Rare Diseases Conference ... SMi reports: Invitation from conference co-chair released for the 9th Annual Orphan Drugs & Rare Diseases conference, taking place in London this October
Partner Content Partner Content Pre-Filled Syringes - Chemical Compatibility and Design Stra... Insight in Pre-Filled Syringe Deisgn
News Jazz gets first FDA nod for HER2 bispecific Ziihera Jazz Pharma has claimed FDA approval for its HER2-directed bispecific antibody Ziihera as a treatment for biliary tract cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
